Engineering the Brain Back to Health | Edward Chang, M.D.

Partially SupportedNewer cell therapies for Parkinson's disease utilize improved cell models and delivery systems for better control over dopamine release.

Partially SupportedSynthetic cells could be engineered to produce dopamine for treating conditions like Parkinson's disease.

Partially SupportedStem cell-like interventions for central nervous system regeneration are seeing renewed interest due to advances in cell-based therapies and organoids.

Partially SupportedThe near-term focus for cell-based therapies is on non-purely synthesized cell cultures.

Partially SupportedTransplanting stem cells to replace degenerating dopaminergic neurons in the substantia nigra is a potential therapeutic strategy for Parkinson's disease.